For example, an in vitro study demonstrated that letrozole (an aromatase inhibitor), decreased cell proliferation in ER expressing cell lines [35] which was confirmed in an independent in vivo experiment where treatment with exemestane (another aromatase inhibitor), resulted in significant tumor reduction in human lung tumor xenografts [61]. The gene discussed is CYP19A1; the disease is neoplasm.